Pediatric transplantation in Europe during the COVID-19 pandemic : Early impact on activity and healthcare
(2020) In Clinical Transplantation 34(10).- Abstract
The current pandemic SARS-CoV-2 has required an unusual allocation of resources that can negatively impact chronically ill patients and high-complexity procedures. Across the European Reference Network on Pediatric Transplantation (ERN TransplantChild), we conducted a survey to investigate the impact of the COVID-19 outbreak on pediatric transplant activity and healthcare practices in both solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). The replies of 30 professionals from 18 centers in Europe were collected. Twelve of 18 centers (67%) showed a reduction in their usual transplant activity. Additionally, outpatient visits have been modified and restricted to selected ones, and the use of telemedicine... (More)
The current pandemic SARS-CoV-2 has required an unusual allocation of resources that can negatively impact chronically ill patients and high-complexity procedures. Across the European Reference Network on Pediatric Transplantation (ERN TransplantChild), we conducted a survey to investigate the impact of the COVID-19 outbreak on pediatric transplant activity and healthcare practices in both solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). The replies of 30 professionals from 18 centers in Europe were collected. Twelve of 18 centers (67%) showed a reduction in their usual transplant activity. Additionally, outpatient visits have been modified and restricted to selected ones, and the use of telemedicine tools has increased. Additionally, a total of 14 COVID-19 pediatric transplanted patients were identified at the time of the survey, including eight transplant recipients and six candidates for transplantation. Only two moderate-severe cases were reported, both in HSCT setting. These survey results demonstrate the limitations in healthcare resources for pediatric transplantation patients during early stages of this pandemic. COVID-19 disease is a major worldwide challenge for the field of pediatric transplantation, where there will be a need for systematic data collection, encouraging regular discussions to address the long-term consequences for pediatric transplantation candidates, recipients, and their families.
(Less)
- author
- publishing date
- 2020-10
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- adolescents, children, coronavirus disease 2019, COVID-19, hematopoietic stem cell transplantation, pediatric transplantation, post-transplant management, SARS-CoV-2, solid organ transplantation, young
- in
- Clinical Transplantation
- volume
- 34
- issue
- 10
- article number
- e14063
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:32786120
- scopus:85091288163
- ISSN
- 0902-0063
- DOI
- 10.1111/ctr.14063
- language
- English
- LU publication?
- no
- id
- 0bb61e33-31d1-4afa-aa9b-a34be4d1457b
- date added to LUP
- 2020-11-04 12:25:06
- date last changed
- 2024-05-15 20:10:56
@article{0bb61e33-31d1-4afa-aa9b-a34be4d1457b,
abstract = {{<p>The current pandemic SARS-CoV-2 has required an unusual allocation of resources that can negatively impact chronically ill patients and high-complexity procedures. Across the European Reference Network on Pediatric Transplantation (ERN TransplantChild), we conducted a survey to investigate the impact of the COVID-19 outbreak on pediatric transplant activity and healthcare practices in both solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). The replies of 30 professionals from 18 centers in Europe were collected. Twelve of 18 centers (67%) showed a reduction in their usual transplant activity. Additionally, outpatient visits have been modified and restricted to selected ones, and the use of telemedicine tools has increased. Additionally, a total of 14 COVID-19 pediatric transplanted patients were identified at the time of the survey, including eight transplant recipients and six candidates for transplantation. Only two moderate-severe cases were reported, both in HSCT setting. These survey results demonstrate the limitations in healthcare resources for pediatric transplantation patients during early stages of this pandemic. COVID-19 disease is a major worldwide challenge for the field of pediatric transplantation, where there will be a need for systematic data collection, encouraging regular discussions to address the long-term consequences for pediatric transplantation candidates, recipients, and their families.</p>}},
author = {{Doná, Daniele and Torres Canizales, Juan and Benetti, Elisa and Cananzi, Mara and De Corti, Federica and Calore, Elisabetta and Hierro, Loreto and Ramos Boluda, Esther and Melgosa Hijosa, Marta and Garcia Guereta, Luis and Pérez Martínez, Antonio and Barrios, Maribel and Costa Reis, Patricia and Teixeira, Ana and Lopes, Maria Francelina and Kaliciński, Piotr and Branchereau, Sophie and Boyer, Olivia and Debray, Dominque and Sciveres, Marco and Wennberg, Lars and Fischler, Björn and Barany, Peter and Baker, Alastair and Baumann, Ulrich and Schwerk, Nicolaus and Nicastro, Emanuele and Candusso, Manila and Toporski, Jacek and Sokal, Etienne and Stephenne, Xavier and Lindemans, Caroline and Miglinas, Marius and Rascon, Jelena and Jara, Paloma}},
issn = {{0902-0063}},
keywords = {{adolescents; children; coronavirus disease 2019; COVID-19; hematopoietic stem cell transplantation; pediatric transplantation; post-transplant management; SARS-CoV-2; solid organ transplantation; young}},
language = {{eng}},
number = {{10}},
publisher = {{Wiley-Blackwell}},
series = {{Clinical Transplantation}},
title = {{Pediatric transplantation in Europe during the COVID-19 pandemic : Early impact on activity and healthcare}},
url = {{http://dx.doi.org/10.1111/ctr.14063}},
doi = {{10.1111/ctr.14063}},
volume = {{34}},
year = {{2020}},
}